Pages

Wednesday, July 24, 2019

Keytruda: 'I owe it everything': cancer drug approval win for rare cancers

Paul Hazelwood was told there was nothing else doctors could do to treat his rare terminal cancer.
Three and a half years later he is still living with stage 4 small bowel cancer, a fact he puts down to a medical trial and a cancer drug called Keytruda.
"I owe it everything," Mr Hazelwood, 44, said.
Keytruda - 'I owe it everything': cancer drug approval win for rare cancers


First assisted dying permit issued to terminally ill Victorian


Labor MP Peta Murphy receives cancer diagnosis two weeks before first speech